Type
Walree, Lunteren. A study of medical data on leprosy patients of three healthcentres in western Kenya. s.l.; 1982 p. 27 p.
Type
Bemnet. The attitudes of Mutomo-Kitoo (Kitui-Kenya) people towards leprosy. Amsterdam: Royal Tropical Institute; p. 14 p.
Type
Mira MT, Boldt A, Kun J, Prevedello FC, Sanchez MI, Stahlke E, et al. Susceptibility to Leprosy is Associated with M-ficolin Polymorphisms. Journal of clinical immunology. 2012;.
Type
Hong W, Deng W, Xie J. The Structure, Function, and Regulation of Mycobacterium FtsZ. Cell biochemistry and biophysics. 2012;.
Type
Nakata N, Kai M, Makino M. Mutation Analysis of Mycobacterial rpoB Genes and Rifampin Resistance Using Recombinant Mycobacterium smegmatis. Antimicrob. Agents Chemother. 2012;56(4):2008-13.
Type
Mateen F, Carone M, Haskew C, Spiegel P. Reportable neurologic diseases in refugee camps in 19 countries. Neurology. 2012;79(9):937-40.
Type
Yamaguchi S, Yamamoto Y, Hosokawa A, Hagiwara K, Uezato H, Takahashi K. Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy. The Journal of dermatology. 2012;39(8):711-4.
Type
García-Moreno E, Marín-Arriaza M, Navarro-Martínez D, Martínez-Lirola M. [Molecular confirmation of an especially difficult to diagnose case of leprosy]. Enfermedades infecciosas y microbiologia clinica. 2012;30(5):276-7.
Type
Desikan. Elimination of leprosy & possibility of eradication - the Indian scenario. The Indian journal of medical research [Internet]. 2012;135:3-5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307180/?report=printable
Type
Legendre D, Muzny C, Swiatlo E. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. Pharmacotherapy. 2012;32(1):27-37.